Model 1 with TTE | Model 2 with Age at Onset | Model 3 with Age at Diagnosis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | Coeff | 95% CI | p-value |  | Coeff | 95% CI | p-value |  | Coeff | 95% CI | p-value |
TTE | -0.37 | -1.19—0.45 | 0.375 | Age at Onset | 0.80 | -0.62—2.22 | 0.270 | Age at Diagnosis | 0.91 | -0.67—2.49 | 0.260 |
TTE2 | 0.02 | -0.03—0.06 | 0.482 | Age at Onset2 | -0.005 | -0.01—0.05 | 0.339 | Age at diagnosis2 | -0.01 | -0.02—0.05 | 0.299 |
Sex | Â | Â | Â | Sex | Â | Â | Â | Sex | Â | Â | Â |
Male | -0.48 | -1.87—0.91 | 0.500 | Male | -0.15 | -1.52—1.22 | 0.826 | Male | -0.19 | -1.55—1.81 | 0.789 |
Years of Education | Â | Â | Â | Years of Education | Â | Â | Â | Years of Education | Â | Â | Â |
8 to 12 years | 1.38 | -0.14—2.90 | 0.075 | 8 to 12 years | 1.34 | -0.15—2.84 | 0.078 | 8 to 12 years | 1.45 | -0.04—2.95 | 0.057 |
 ≥ 13 years | 4.07 | 1.90—6.25 |  < 0.0001 |  ≥ 13 years | 4.15 | 2.00—6.31 |  < 0.0001 |  ≥ 13 years | 4.27 | 2.11—6.43 |  < 0.0001 |
Comorbidity Score | Â | Â | Â | Comorbidity Score | Â | Â | Â | Comorbidity Score | Â | Â | Â |
3 to 4 | 0.95 | -0.51—2.41 | 0.201 | 3 to 4 | 0.83 | -0.62—2.28 | 0.259 | 3 to 4 | 0.95 | -0.50—2.39 | 0.200 |
 ≥ 5 | 1.63 | -0.04—3.31 | 0.056 |  ≥ 5 | 1.44 | -0.23—3.10 | 0.091 |  ≥ 5 | 1.50 | -0.13—3.14 | 0.072 |
Dementia Subtype | Â | Â | Â | Dementia Subtype | Â | Â | Â | Dementia Subtype | Â | Â | Â |
VND | 2.37 | 0.43—4.31 | 0.017 | VND | 2.81 | 0.88—4.74 | 0.004 | VND | 2.82 | 0.87—4.77 | 0.005 |
DLB/PDD | -0.16 | -2.64—2.32 | 0.901 | DLB/PDD | 0.05 | -2.34—2.44 | 0.968 | DLB/PDD | 0.07 | -2.34—2.49 | 0.951 |
FTD | 0.25 | -4.80—5.30 | 0.923 | FTD | 0.93 | -4.08—5.94 | 0.716 | FTD | 0.39 | -4.63—5.42 | 0.878 |